HEADER SIGNALING PROTEIN 28-NOV-19 6TKO TITLE PHOSPHORYLATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL TITLE 2 COUPLED TO ARRESTIN-2 IN LIPID NANODISC. COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-1 ADRENERGIC RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-1 ADRENORECEPTOR,BETA-T; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: RELATIVE TO WILD-TYPE SEQUENCE: CONSTRUCT IS TRUNCATED COMPND 8 AT THE N-TERMINUS; AND IN ICL3; ITS C-TERMINUS IS TRUNCATED AT C358A COMPND 9 AND FUSED WITH A LINKER TO A SERIES OF PHOSPHORYLATED RESIDUES COMPND 10 (ARGRPLPETGGGDE[PS]A[PT][PT]A[PS][PS][PS]LAKDTSS).; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: BETA-ARRESTIN-1; COMPND 13 CHAIN: B; COMPND 14 SYNONYM: ARRESTIN BETA-1,NON-VISUAL ARRESTIN-2; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 OTHER_DETAILS: ADDITIONAL N-TERMINAL GLY RESIDUE, IN PLACE OF COMPND 18 STARTING MET, REMAINING FROM PROTEOLYTIC CLEAVAGE.; COMPND 19 MOL_ID: 3; COMPND 20 MOLECULE: FAB30 HEAVY CHAIN; COMPND 21 CHAIN: H; COMPND 22 ENGINEERED: YES; COMPND 23 MOL_ID: 4; COMPND 24 MOLECULE: FAB30 LIGHT CHAIN; COMPND 25 CHAIN: L; COMPND 26 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO; SOURCE 3 ORGANISM_COMMON: WILD TURKEY; SOURCE 4 ORGANISM_TAXID: 9103; SOURCE 5 GENE: ADRB1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: ARRB1, ARR1; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: PHAGE DISPLAY VECTOR PTDISP; SOURCE 18 ORGANISM_TAXID: 279974; SOURCE 19 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 21 MOL_ID: 4; SOURCE 22 ORGANISM_SCIENTIFIC: PHAGE DISPLAY VECTOR PTDISP; SOURCE 23 ORGANISM_TAXID: 279974; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GPCR, ARRESTIN, COMPLEX, NANODISC, SIGNALING PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.LEE,C.G.TATE REVDAT 4 16-OCT-24 6TKO 1 JRNL REMARK REVDAT 3 12-AUG-20 6TKO 1 JRNL REVDAT 2 08-JUL-20 6TKO 1 JRNL REVDAT 1 17-JUN-20 6TKO 0 JRNL AUTH Y.LEE,T.WARNE,R.NEHME,S.PANDEY,H.DWIVEDI-AGNIHOTRI, JRNL AUTH 2 M.CHATURVEDI,P.C.EDWARDS,J.GARCIA-NAFRIA,A.G.W.LESLIE, JRNL AUTH 3 A.K.SHUKLA,C.G.TATE JRNL TITL MOLECULAR BASIS OF BETA-ARRESTIN COUPLING TO JRNL TITL 2 FORMOTEROL-BOUND BETA1-ADRENOCEPTOR. JRNL REF NATURE V. 583 862 2020 JRNL REFN ESSN 1476-4687 JRNL PMID 32555462 JRNL DOI 10.1038/S41586-020-2419-1 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.LEE,T.WARNE,R.NEHME,S.PANDEY,H.DWIVEDI-AGNIHOTRI, REMARK 1 AUTH 2 P.C.EDWARDS,J.GARCIA-NAFRIA,A.G.W.LESLIE,A.K.SHUKLA,C.G.TATE REMARK 1 TITL MOLECULAR DETERMINANTS OF BETA-ARRESTIN COUPLING TO REMARK 1 TITL 2 FORMOTEROL-BOUND BETA1-ADRENOCEPTOR. REMARK 1 REF BIORXIV 2020 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2020.03.27.011585V1 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : SERIALEM, WARP, RELION, COOT, EPU, REMARK 3 RELION, RELION, RELION, PHENIX, REFMAC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 6IBL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : OTHER REMARK 3 REFINEMENT TARGET : CORRELATION COEFFICIENT REMARK 3 OVERALL ANISOTROPIC B VALUE : 80.600 REMARK 3 REMARK 3 FITTING PROCEDURE : INITIAL PLACEMENT WAS DONE MANUALLY IN COOT, REMARK 3 FOLLOWED BY RIGID-BODY REFINEMENT IN PHENIX AND JELLY-BODY REMARK 3 REFINEMENT IN REFMAC5. MANUAL REMODELING WAS PERFORMED IN COOT REMARK 3 AND ITERATED WITH REAL SPACE REFINEMENT IN PHENIX. CHEMICAL REMARK 3 RESTRAINTS FOR FORMOTEROL WERE CALCULATED IN ELBOW USING AM1 REMARK 3 OPTIMISATION. REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 403991 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: HALF MAPS WERE LOCALLY FILTERED BETWEEN REFINEMENT REMARK 3 ITERATIONS USING SIDESPLITTER, AN ADAPTATION OF THE LAFTER REMARK 3 ALGORITHM THAT MAINTAINS GOLD-STANDARD SEPARATION BETWEEN THE REMARK 3 TWO HALF MAPS. REMARK 4 REMARK 4 6TKO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292105614. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FORMOTEROL-BOUND BETA1 REMARK 245 -ADRENOCEPTOR COUPLED TO BETA- REMARK 245 ARRESTIN-1 STABILISED BY FAB30.; REMARK 245 BETA-1 ADRENERGIC RECEPTOR; REMARK 245 BETA-ARRESTIN-1; FAB30 HEAVY REMARK 245 CHAIN; FAB30 LIGHT CHAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOTTED FOR 2-3 SECONDS BEFORE REMARK 245 PLUNGING. LIQUID ETHANE REMARK 245 MAINTAINED AT 92.15 K. REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : COMPLEX FORMED IN LIPID REMARK 245 NANODISC. REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS; FEI TITAN REMARK 245 KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K); REMARK 245 GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00; 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00; 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70; 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD; BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00; 4500.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM; FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000; 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN; FIELD REMARK 245 EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300; 300 REMARK 245 IMAGING DETAILS : DATA COLLECTED WITH A STAGE REMARK 245 -TILT OF 30DEG; TWO NON-OVERLAPPING EXPOSURES PER HOLE AND MULTI- REMARK 245 HOLE IMAGE-SHIFT DATA ACQUISITION STRATEGIES (3X3 HOLES PER REMARK 245 STAGE SHIFT).; DATA COLLECTED WITH A STAGE-TILT OF 30DEG; TWO REMARK 245 NON-OVERLAPPING EXPOSURES PER HOLE USING IMAGE-SHIFT. REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 32 REMARK 465 ALA A 33 REMARK 465 GLU A 34 REMARK 465 LEU A 35 REMARK 465 LEU A 36 REMARK 465 SER A 37 REMARK 465 GLN A 38 REMARK 465 GLN A 39 REMARK 465 TRP A 40 REMARK 465 GLU A 41 REMARK 465 ARG A 271 REMARK 465 ALA A 272 REMARK 465 SER A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 LYS A 276 REMARK 465 THR A 277 REMARK 465 SER A 278 REMARK 465 ARG A 279 REMARK 465 ALA A 1343 REMARK 465 ARG A 1344 REMARK 465 GLY A 1345 REMARK 465 ARG A 1346 REMARK 465 PRO A 1347 REMARK 465 LEU A 1348 REMARK 465 PRO A 1349 REMARK 465 GLU A 1350 REMARK 465 THR A 1351 REMARK 465 GLY A 1352 REMARK 465 GLY A 1353 REMARK 465 GLY A 1354 REMARK 465 ASP A 1355 REMARK 465 THR A 1369 REMARK 465 SER A 1370 REMARK 465 SER A 1371 REMARK 465 GLY B 1 REMARK 465 GLY B 2 REMARK 465 ASP B 3 REMARK 465 LYS B 4 REMARK 465 GLY B 5 REMARK 465 ARG B 331 REMARK 465 GLY B 332 REMARK 465 GLY B 333 REMARK 465 LEU B 334 REMARK 465 LEU B 335 REMARK 465 GLY B 336 REMARK 465 ASP B 337 REMARK 465 LEU B 338 REMARK 465 ALA B 339 REMARK 465 SER B 340 REMARK 465 PRO B 360 REMARK 465 PRO B 361 REMARK 465 HIS B 362 REMARK 465 ARG B 363 REMARK 465 GLU B 364 REMARK 465 VAL B 365 REMARK 465 PRO B 366 REMARK 465 GLU B 367 REMARK 465 ASN B 368 REMARK 465 GLU B 369 REMARK 465 THR B 370 REMARK 465 PRO B 371 REMARK 465 VAL B 372 REMARK 465 ASP B 373 REMARK 465 THR B 374 REMARK 465 ASN B 375 REMARK 465 LEU B 376 REMARK 465 ILE B 377 REMARK 465 GLU B 378 REMARK 465 LEU B 379 REMARK 465 ASP B 380 REMARK 465 THR B 381 REMARK 465 ASN B 382 REMARK 465 ASP B 383 REMARK 465 ASP B 384 REMARK 465 ASP B 385 REMARK 465 ILE B 386 REMARK 465 VAL B 387 REMARK 465 PHE B 388 REMARK 465 GLU B 389 REMARK 465 ASP B 390 REMARK 465 PHE B 391 REMARK 465 ALA B 392 REMARK 465 ARG B 393 REMARK 465 GLN B 394 REMARK 465 ARG B 395 REMARK 465 LEU B 396 REMARK 465 LYS B 397 REMARK 465 GLY B 398 REMARK 465 MET B 399 REMARK 465 LYS B 400 REMARK 465 ASP B 401 REMARK 465 ASP B 402 REMARK 465 LYS B 403 REMARK 465 GLU B 404 REMARK 465 GLU B 405 REMARK 465 GLU B 406 REMARK 465 GLU B 407 REMARK 465 ASP B 408 REMARK 465 GLY B 409 REMARK 465 THR B 410 REMARK 465 GLY B 411 REMARK 465 SER B 412 REMARK 465 PRO B 413 REMARK 465 GLN B 414 REMARK 465 LEU B 415 REMARK 465 ASN B 416 REMARK 465 ASN B 417 REMARK 465 ARG B 418 REMARK 465 GLU H 1 REMARK 465 ILE H 2 REMARK 465 SER H 3 REMARK 465 GLU H 4 REMARK 465 SER H 137 REMARK 465 SER H 138 REMARK 465 LYS H 139 REMARK 465 SER H 140 REMARK 465 THR H 141 REMARK 465 SER H 142 REMARK 465 GLY H 143 REMARK 465 GLY H 144 REMARK 465 THR H 145 REMARK 465 SER H 197 REMARK 465 SER H 198 REMARK 465 LEU H 199 REMARK 465 GLY H 200 REMARK 465 THR H 201 REMARK 465 GLN H 202 REMARK 465 LYS H 224 REMARK 465 SER H 225 REMARK 465 CYS H 226 REMARK 465 ASP H 227 REMARK 465 LYS H 228 REMARK 465 THR H 229 REMARK 465 HIS H 230 REMARK 465 HIS H 231 REMARK 465 HIS H 232 REMARK 465 HIS H 233 REMARK 465 HIS H 234 REMARK 465 HIS H 235 REMARK 465 HIS H 236 REMARK 465 HIS H 237 REMARK 465 GLY L 201 REMARK 465 LEU L 202 REMARK 465 SER L 203 REMARK 465 CYS L 215 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 48 CG SD CE REMARK 470 GLU A 115 CG CD OE1 OE2 REMARK 470 ILE A 177 CG1 CG2 CD1 REMARK 470 MET A 178 CG SD CE REMARK 470 MET A 179 CG SD CE REMARK 470 ILE A 241 CG1 CG2 CD1 REMARK 470 ASP A 242 CG OD1 OD2 REMARK 470 VAL A 280 CG1 CG2 REMARK 470 MET A 281 CG SD CE REMARK 470 MET A 283 CG SD CE REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 285 CG CD OE1 OE2 REMARK 470 HIS A 286 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 LYS A 290 CG CD CE NZ REMARK 470 LEU A 308 CG CD1 CD2 REMARK 470 ILE A 311 CG1 CG2 CD1 REMARK 470 VAL A 312 CG1 CG2 REMARK 470 VAL A 314 CG1 CG2 REMARK 470 ASN A 316 CG OD1 ND2 REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 318 CG OD1 OD2 REMARK 470 LEU A 319 CG CD1 CD2 REMARK 470 VAL A 320 CG1 CG2 REMARK 470 LYS A 322 CG CD CE NZ REMARK 470 LEU A 324 CG CD1 CD2 REMARK 470 LEU A 331 CG CD1 CD2 REMARK 470 GLU A1356 CG CD OE1 OE2 REMARK 470 LYS A1367 CG CD CE NZ REMARK 470 LYS B 17 CG CD CE NZ REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 GLU B 92 CG CD OE1 OE2 REMARK 470 GLU B 134 CG CD OE1 OE2 REMARK 470 HIS B 159 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 191 CG CD1 CD2 REMARK 470 MET B 192 CG SD CE REMARK 470 SER B 193 OG REMARK 470 ASP B 194 CG OD1 OD2 REMARK 470 ASN B 311 CG OD1 ND2 REMARK 470 SER B 341 OG REMARK 470 LYS B 357 CG CD CE NZ REMARK 470 GLU B 358 CG CD OE1 OE2 REMARK 470 GLU B 359 CG CD OE1 OE2 REMARK 470 ASP H 65 CG OD1 OD2 REMARK 470 ASP H 154 CG OD1 OD2 REMARK 470 GLU H 158 CG CD OE1 OE2 REMARK 470 ASN H 207 CG OD1 ND2 REMARK 470 LYS H 216 CG CD CE NZ REMARK 470 SER L 1 OG REMARK 470 ASP L 2 CG OD1 OD2 REMARK 470 GLU L 106 CG CD OE1 OE2 REMARK 470 LYS L 127 CG CD CE NZ REMARK 470 GLU L 214 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 13 OD1 ASN B 15 2.08 REMARK 500 OG SER H 36 OG SER H 102 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 145 67.75 -118.93 REMARK 500 VAL H 51 -61.39 -95.65 REMARK 500 PRO H 157 -163.22 -71.10 REMARK 500 SER L 31 -169.48 -78.74 REMARK 500 ALA L 52 -5.49 72.84 REMARK 500 ASN L 159 49.64 38.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H98 A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLU A 1356 and SEP A REMARK 800 1357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide SEP A 1357 and ALA A REMARK 800 1358 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA A 1358 and TPO A REMARK 800 1359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues TPO A 1359 and TPO A REMARK 800 1360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide TPO A 1360 and ALA A REMARK 800 1361 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA A 1361 and SEP A REMARK 800 1362 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues SEP A 1362 and SEP A REMARK 800 1363 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues SEP A 1363 and SEP A REMARK 800 1364 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide SEP A 1364 and LEU A REMARK 800 1365 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6IBL RELATED DB: PDB REMARK 900 6IBL CONTAINS THE SAME AGONIST-BOUND RECEPTOR COMPLEXED WITH REMARK 900 NANOBODY NB80. REMARK 900 RELATED ID: EMD-10515 RELATED DB: EMDB REMARK 900 PHOSPHORYLATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST REMARK 900 FORMOTEROL COUPLED TO ARRESTIN-2 IN LIPID NANODISC. DBREF 6TKO A 32 357 UNP P07700 ADRB1_MELGA 32 357 DBREF 6TKO B 1 418 UNP P49407 ARRB1_HUMAN 1 418 DBREF 6TKO H 1 237 PDB 6TKO 6TKO 1 237 DBREF 6TKO L 1 215 PDB 6TKO 6TKO 1 215 SEQADV 6TKO GLY A 32 UNP P07700 SER 32 ENGINEERED MUTATION SEQADV 6TKO CYS A 44 UNP P07700 MET 44 ENGINEERED MUTATION SEQADV 6TKO VAL A 90 UNP P07700 MET 90 ENGINEERED MUTATION SEQADV 6TKO CYS A 103 UNP P07700 VAL 103 ENGINEERED MUTATION SEQADV 6TKO LEU A 116 UNP P07700 CYS 116 ENGINEERED MUTATION SEQADV 6TKO TRP A 130 UNP P07700 GLU 130 ENGINEERED MUTATION SEQADV 6TKO LYS A 322 UNP P07700 ASP 322 ENGINEERED MUTATION SEQADV 6TKO ALA A 327 UNP P07700 PHE 327 ENGINEERED MUTATION SEQADV 6TKO MET A 338 UNP P07700 PHE 338 ENGINEERED MUTATION SEQADV 6TKO ALA A 358 UNP P07700 EXPRESSION TAG SEQADV 6TKO ALA A 1343 UNP P07700 EXPRESSION TAG SEQADV 6TKO ARG A 1344 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLY A 1345 UNP P07700 EXPRESSION TAG SEQADV 6TKO ARG A 1346 UNP P07700 EXPRESSION TAG SEQADV 6TKO PRO A 1347 UNP P07700 EXPRESSION TAG SEQADV 6TKO LEU A 1348 UNP P07700 EXPRESSION TAG SEQADV 6TKO PRO A 1349 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLU A 1350 UNP P07700 EXPRESSION TAG SEQADV 6TKO THR A 1351 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLY A 1352 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLY A 1353 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLY A 1354 UNP P07700 EXPRESSION TAG SEQADV 6TKO ASP A 1355 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLU A 1356 UNP P07700 EXPRESSION TAG SEQADV 6TKO SEP A 1357 UNP P07700 EXPRESSION TAG SEQADV 6TKO ALA A 1358 UNP P07700 EXPRESSION TAG SEQADV 6TKO TPO A 1359 UNP P07700 EXPRESSION TAG SEQADV 6TKO TPO A 1360 UNP P07700 EXPRESSION TAG SEQADV 6TKO ALA A 1361 UNP P07700 EXPRESSION TAG SEQADV 6TKO SEP A 1362 UNP P07700 EXPRESSION TAG SEQADV 6TKO SEP A 1363 UNP P07700 EXPRESSION TAG SEQADV 6TKO SEP A 1364 UNP P07700 EXPRESSION TAG SEQADV 6TKO LEU A 1365 UNP P07700 EXPRESSION TAG SEQADV 6TKO ALA A 1366 UNP P07700 EXPRESSION TAG SEQADV 6TKO LYS A 1367 UNP P07700 EXPRESSION TAG SEQADV 6TKO ASP A 1368 UNP P07700 EXPRESSION TAG SEQADV 6TKO THR A 1369 UNP P07700 EXPRESSION TAG SEQADV 6TKO SER A 1370 UNP P07700 EXPRESSION TAG SEQADV 6TKO SER A 1371 UNP P07700 EXPRESSION TAG SEQADV 6TKO GLY B 1 UNP P49407 MET 1 ENGINEERED MUTATION SEQADV 6TKO CYS B 68 UNP P49407 LEU 68 ENGINEERED MUTATION SEQADV 6TKO GLU B 169 UNP P49407 ARG 169 ENGINEERED MUTATION SEQRES 1 A 328 GLY ALA GLU LEU LEU SER GLN GLN TRP GLU ALA GLY CYS SEQRES 2 A 328 SER LEU LEU MET ALA LEU VAL VAL LEU LEU ILE VAL ALA SEQRES 3 A 328 GLY ASN VAL LEU VAL ILE ALA ALA ILE GLY ARG THR GLN SEQRES 4 A 328 ARG LEU GLN THR LEU THR ASN LEU PHE ILE THR SER LEU SEQRES 5 A 328 ALA CYS ALA ASP LEU VAL VAL GLY LEU LEU VAL VAL PRO SEQRES 6 A 328 PHE GLY ALA THR LEU VAL CYS ARG GLY THR TRP LEU TRP SEQRES 7 A 328 GLY SER PHE LEU CYS GLU LEU TRP THR SER LEU ASP VAL SEQRES 8 A 328 LEU CYS VAL THR ALA SER ILE TRP THR LEU CYS VAL ILE SEQRES 9 A 328 ALA ILE ASP ARG TYR LEU ALA ILE THR SER PRO PHE ARG SEQRES 10 A 328 TYR GLN SER LEU MET THR ARG ALA ARG ALA LYS VAL ILE SEQRES 11 A 328 ILE CYS THR VAL TRP ALA ILE SER ALA LEU VAL SER PHE SEQRES 12 A 328 LEU PRO ILE MET MET HIS TRP TRP ARG ASP GLU ASP PRO SEQRES 13 A 328 GLN ALA LEU LYS CYS TYR GLN ASP PRO GLY CYS CYS ASP SEQRES 14 A 328 PHE VAL THR ASN ARG ALA TYR ALA ILE ALA SER SER ILE SEQRES 15 A 328 ILE SER PHE TYR ILE PRO LEU LEU ILE MET ILE PHE VAL SEQRES 16 A 328 TYR LEU ARG VAL TYR ARG GLU ALA LYS GLU GLN ILE ARG SEQRES 17 A 328 LYS ILE ASP ARG ALA SER LYS ARG LYS THR SER ARG VAL SEQRES 18 A 328 MET ALA MET ARG GLU HIS LYS ALA LEU LYS THR LEU GLY SEQRES 19 A 328 ILE ILE MET GLY VAL PHE THR LEU CYS TRP LEU PRO PHE SEQRES 20 A 328 PHE LEU VAL ASN ILE VAL ASN VAL PHE ASN ARG ASP LEU SEQRES 21 A 328 VAL PRO LYS TRP LEU PHE VAL ALA PHE ASN TRP LEU GLY SEQRES 22 A 328 TYR ALA ASN SER ALA MET ASN PRO ILE ILE TYR CYS ARG SEQRES 23 A 328 SER PRO ASP PHE ARG LYS ALA PHE LYS ARG LEU LEU ALA SEQRES 24 A 328 ALA ARG GLY ARG PRO LEU PRO GLU THR GLY GLY GLY ASP SEQRES 25 A 328 GLU SEP ALA TPO TPO ALA SEP SEP SEP LEU ALA LYS ASP SEQRES 26 A 328 THR SER SER SEQRES 1 B 418 GLY GLY ASP LYS GLY THR ARG VAL PHE LYS LYS ALA SER SEQRES 2 B 418 PRO ASN GLY LYS LEU THR VAL TYR LEU GLY LYS ARG ASP SEQRES 3 B 418 PHE VAL ASP HIS ILE ASP LEU VAL ASP PRO VAL ASP GLY SEQRES 4 B 418 VAL VAL LEU VAL ASP PRO GLU TYR LEU LYS GLU ARG ARG SEQRES 5 B 418 VAL TYR VAL THR LEU THR CYS ALA PHE ARG TYR GLY ARG SEQRES 6 B 418 GLU ASP CYS ASP VAL LEU GLY LEU THR PHE ARG LYS ASP SEQRES 7 B 418 LEU PHE VAL ALA ASN VAL GLN SER PHE PRO PRO ALA PRO SEQRES 8 B 418 GLU ASP LYS LYS PRO LEU THR ARG LEU GLN GLU ARG LEU SEQRES 9 B 418 ILE LYS LYS LEU GLY GLU HIS ALA TYR PRO PHE THR PHE SEQRES 10 B 418 GLU ILE PRO PRO ASN LEU PRO CYS SER VAL THR LEU GLN SEQRES 11 B 418 PRO GLY PRO GLU ASP THR GLY LYS ALA CYS GLY VAL ASP SEQRES 12 B 418 TYR GLU VAL LYS ALA PHE CYS ALA GLU ASN LEU GLU GLU SEQRES 13 B 418 LYS ILE HIS LYS ARG ASN SER VAL ARG LEU VAL ILE GLU SEQRES 14 B 418 LYS VAL GLN TYR ALA PRO GLU ARG PRO GLY PRO GLN PRO SEQRES 15 B 418 THR ALA GLU THR THR ARG GLN PHE LEU MET SER ASP LYS SEQRES 16 B 418 PRO LEU HIS LEU GLU ALA SER LEU ASP LYS GLU ILE TYR SEQRES 17 B 418 TYR HIS GLY GLU PRO ILE SER VAL ASN VAL HIS VAL THR SEQRES 18 B 418 ASN ASN THR ASN LYS THR VAL LYS LYS ILE LYS ILE SER SEQRES 19 B 418 VAL ARG GLN TYR ALA ASP ILE CYS LEU PHE ASN THR ALA SEQRES 20 B 418 GLN TYR LYS CYS PRO VAL ALA MET GLU GLU ALA ASP ASP SEQRES 21 B 418 THR VAL ALA PRO SER SER THR PHE CYS LYS VAL TYR THR SEQRES 22 B 418 LEU THR PRO PHE LEU ALA ASN ASN ARG GLU LYS ARG GLY SEQRES 23 B 418 LEU ALA LEU ASP GLY LYS LEU LYS HIS GLU ASP THR ASN SEQRES 24 B 418 LEU ALA SER SER THR LEU LEU ARG GLU GLY ALA ASN ARG SEQRES 25 B 418 GLU ILE LEU GLY ILE ILE VAL SER TYR LYS VAL LYS VAL SEQRES 26 B 418 LYS LEU VAL VAL SER ARG GLY GLY LEU LEU GLY ASP LEU SEQRES 27 B 418 ALA SER SER ASP VAL ALA VAL GLU LEU PRO PHE THR LEU SEQRES 28 B 418 MET HIS PRO LYS PRO LYS GLU GLU PRO PRO HIS ARG GLU SEQRES 29 B 418 VAL PRO GLU ASN GLU THR PRO VAL ASP THR ASN LEU ILE SEQRES 30 B 418 GLU LEU ASP THR ASN ASP ASP ASP ILE VAL PHE GLU ASP SEQRES 31 B 418 PHE ALA ARG GLN ARG LEU LYS GLY MET LYS ASP ASP LYS SEQRES 32 B 418 GLU GLU GLU GLU ASP GLY THR GLY SER PRO GLN LEU ASN SEQRES 33 B 418 ASN ARG SEQRES 1 H 237 GLU ILE SER GLU VAL GLN LEU VAL GLU SER GLY GLY GLY SEQRES 2 H 237 LEU VAL GLN PRO GLY GLY SER LEU ARG LEU SER CYS ALA SEQRES 3 H 237 ALA SER GLY PHE ASN VAL TYR SER SER SER ILE HIS TRP SEQRES 4 H 237 VAL ARG GLN ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA SEQRES 5 H 237 SER ILE SER SER TYR TYR GLY TYR THR TYR TYR ALA ASP SEQRES 6 H 237 SER VAL LYS GLY ARG PHE THR ILE SER ALA ASP THR SER SEQRES 7 H 237 LYS ASN THR ALA TYR LEU GLN MET ASN SER LEU ARG ALA SEQRES 8 H 237 GLU ASP THR ALA VAL TYR TYR CYS ALA ARG SER ARG GLN SEQRES 9 H 237 PHE TRP TYR SER GLY LEU ASP TYR TRP GLY GLN GLY THR SEQRES 10 H 237 LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 H 237 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 H 237 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 H 237 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 H 237 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 H 237 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 H 237 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 H 237 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 H 237 GLU PRO LYS SER CYS ASP LYS THR HIS HIS HIS HIS HIS SEQRES 19 H 237 HIS HIS HIS SEQRES 1 L 215 SER ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER SEQRES 2 L 215 ALA SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SEQRES 3 L 215 SER GLN SER VAL SER SER ALA VAL ALA TRP TYR GLN GLN SEQRES 4 L 215 LYS PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR SER ALA SEQRES 5 L 215 SER SER LEU TYR SER GLY VAL PRO SER ARG PHE SER GLY SEQRES 6 L 215 SER ARG SER GLY THR ASP PHE THR LEU THR ILE SER SER SEQRES 7 L 215 LEU GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLN SEQRES 8 L 215 TYR LYS TYR VAL PRO VAL THR PHE GLY GLN GLY THR LYS SEQRES 9 L 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 215 ILE PHE PRO PRO SER ASP SER GLN LEU LYS SER GLY THR SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 L 215 SER PHE ASN ARG GLY GLU CYS HET SEP A1357 10 HET TPO A1359 11 HET TPO A1360 11 HET SEP A1362 10 HET SEP A1363 10 HET SEP A1364 10 HET H98 A2001 25 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM H98 ~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-METHOXYPHENYL)PROPAN- HETNAM 2 H98 2-YL]AMINO]-1-OXIDANYL-ETHYL]-2-OXIDANYL- HETNAM 3 H98 PHENYL]METHANAMIDE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 4(C3 H8 N O6 P) FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 H98 C19 H24 N2 O4 HELIX 1 AA1 CYS A 44 THR A 69 1 26 HELIX 2 AA2 THR A 74 GLY A 105 1 32 HELIX 3 AA3 GLY A 110 THR A 144 1 35 HELIX 4 AA4 SER A 145 MET A 153 1 9 HELIX 5 AA5 THR A 154 HIS A 180 1 27 HELIX 6 AA6 ASP A 186 ASP A 195 1 10 HELIX 7 AA7 ASN A 204 PHE A 216 1 13 HELIX 8 AA8 PHE A 216 ASP A 242 1 27 HELIX 9 AA9 MET A 281 ASN A 316 1 36 HELIX 10 AB1 PRO A 321 CYS A 344 1 24 HELIX 11 AB2 SER A 346 ALA A 358 1 13 HELIX 12 AB3 THR B 98 GLY B 109 1 12 HELIX 13 AB4 ASN B 280 LYS B 284 5 5 HELIX 14 AB5 ARG H 90 THR H 94 5 5 HELIX 15 AB6 GLN L 80 PHE L 84 5 5 HELIX 16 AB7 SER L 122 GLY L 129 1 8 HELIX 17 AB8 LYS L 184 HIS L 190 1 7 SHEET 1 AA1 5 ALA A1361 SEP A1364 0 SHEET 2 AA1 5 ARG B 7 ALA B 12 -1 O VAL B 8 N SEP A1363 SHEET 3 AA1 5 THR B 19 LEU B 22 -1 O LEU B 22 N PHE B 9 SHEET 4 AA1 5 GLY B 39 LEU B 42 -1 O VAL B 40 N TYR B 21 SHEET 5 AA1 5 ALA B 112 PHE B 115 -1 O PHE B 115 N GLY B 39 SHEET 1 AA2 5 ASP B 26 VAL B 28 0 SHEET 2 AA2 5 ARG B 165 VAL B 171 1 O GLU B 169 N PHE B 27 SHEET 3 AA2 5 CYS B 140 ALA B 151 -1 N TYR B 144 O ILE B 168 SHEET 4 AA2 5 ARG B 52 ARG B 62 -1 N TYR B 54 O PHE B 149 SHEET 5 AA2 5 ARG B 76 PHE B 87 -1 O LYS B 77 N PHE B 61 SHEET 1 AA3 5 ASP B 26 VAL B 28 0 SHEET 2 AA3 5 ARG B 165 VAL B 171 1 O GLU B 169 N PHE B 27 SHEET 3 AA3 5 CYS B 140 ALA B 151 -1 N TYR B 144 O ILE B 168 SHEET 4 AA3 5 VAL B 127 LEU B 129 -1 N LEU B 129 O CYS B 140 SHEET 5 AA3 5 ALA B 288 ASP B 290 -1 O LEU B 289 N THR B 128 SHEET 1 AA4 4 THR B 183 THR B 187 0 SHEET 2 AA4 4 LEU B 197 LEU B 203 -1 O ALA B 201 N ALA B 184 SHEET 3 AA4 4 VAL B 220 ASN B 222 -1 O THR B 221 N HIS B 198 SHEET 4 AA4 4 SER B 266 THR B 267 -1 O SER B 266 N ASN B 222 SHEET 1 AA5 4 THR B 183 THR B 187 0 SHEET 2 AA5 4 LEU B 197 LEU B 203 -1 O ALA B 201 N ALA B 184 SHEET 3 AA5 4 ILE B 214 VAL B 218 -1 O ASN B 217 N SER B 202 SHEET 4 AA5 4 LYS B 270 LEU B 274 -1 O LEU B 274 N ILE B 214 SHEET 1 AA6 5 ILE B 207 TYR B 208 0 SHEET 2 AA6 5 ASP B 342 LEU B 351 1 O THR B 350 N TYR B 208 SHEET 3 AA6 5 VAL B 319 VAL B 329 -1 N TYR B 321 O PHE B 349 SHEET 4 AA6 5 VAL B 228 ILE B 241 -1 N SER B 234 O LYS B 324 SHEET 5 AA6 5 ALA B 247 ALA B 258 -1 O ALA B 254 N VAL B 235 SHEET 1 AA7 4 GLN H 6 SER H 10 0 SHEET 2 AA7 4 SER H 20 SER H 28 -1 O ALA H 26 N VAL H 8 SHEET 3 AA7 4 THR H 81 ASN H 87 -1 O MET H 86 N LEU H 21 SHEET 4 AA7 4 PHE H 71 ASP H 76 -1 N SER H 74 O TYR H 83 SHEET 1 AA8 5 TYR H 60 TYR H 63 0 SHEET 2 AA8 5 LEU H 48 SER H 55 -1 N SER H 55 O TYR H 60 SHEET 3 AA8 5 SER H 35 GLN H 42 -1 N TRP H 39 O VAL H 51 SHEET 4 AA8 5 ALA H 95 ARG H 103 -1 O ALA H 100 N HIS H 38 SHEET 5 AA8 5 THR H 117 VAL H 119 -1 O THR H 117 N TYR H 97 SHEET 1 AA9 4 SER H 130 LEU H 134 0 SHEET 2 AA9 4 ALA H 147 TYR H 155 -1 O LEU H 151 N PHE H 132 SHEET 3 AA9 4 TYR H 186 THR H 193 -1 O VAL H 192 N LEU H 148 SHEET 4 AA9 4 HIS H 174 THR H 175 -1 N HIS H 174 O VAL H 191 SHEET 1 AB1 4 SER H 130 LEU H 134 0 SHEET 2 AB1 4 ALA H 147 TYR H 155 -1 O LEU H 151 N PHE H 132 SHEET 3 AB1 4 TYR H 186 THR H 193 -1 O VAL H 192 N LEU H 148 SHEET 4 AB1 4 VAL H 179 LEU H 180 -1 N VAL H 179 O SER H 187 SHEET 1 AB2 3 THR H 161 TRP H 164 0 SHEET 2 AB2 3 ILE H 205 HIS H 210 -1 O ASN H 207 N SER H 163 SHEET 3 AB2 3 THR H 215 LYS H 220 -1 O VAL H 217 N VAL H 208 SHEET 1 AB3 4 MET L 5 SER L 8 0 SHEET 2 AB3 4 VAL L 20 ALA L 26 -1 O ARG L 25 N THR L 6 SHEET 3 AB3 4 ASP L 71 ILE L 76 -1 O LEU L 74 N ILE L 22 SHEET 4 AB3 4 PHE L 63 ARG L 67 -1 N SER L 64 O THR L 75 SHEET 1 AB4 2 SER L 11 ALA L 14 0 SHEET 2 AB4 2 LYS L 104 ILE L 107 1 O GLU L 106 N ALA L 14 SHEET 1 AB5 4 SER L 54 LEU L 55 0 SHEET 2 AB5 4 PRO L 45 TYR L 50 -1 N TYR L 50 O SER L 54 SHEET 3 AB5 4 ALA L 35 GLN L 39 -1 N GLN L 38 O LYS L 46 SHEET 4 AB5 4 THR L 86 GLN L 90 -1 O THR L 86 N GLN L 39 SHEET 1 AB6 4 SER L 115 PHE L 119 0 SHEET 2 AB6 4 THR L 130 PHE L 140 -1 O ASN L 138 N SER L 115 SHEET 3 AB6 4 TYR L 174 SER L 183 -1 O LEU L 182 N ALA L 131 SHEET 4 AB6 4 SER L 160 THR L 165 -1 N THR L 165 O SER L 175 SHEET 1 AB7 4 LEU L 155 GLN L 156 0 SHEET 2 AB7 4 LYS L 146 LYS L 150 -1 N TRP L 149 O GLN L 156 SHEET 3 AB7 4 VAL L 192 THR L 198 -1 O THR L 198 N LYS L 146 SHEET 4 AB7 4 VAL L 206 ASN L 211 -1 O VAL L 206 N VAL L 197 SSBOND 1 CYS A 44 CYS A 103 1555 1555 2.03 SSBOND 2 CYS A 114 CYS A 199 1555 1555 2.03 SSBOND 3 CYS A 192 CYS A 198 1555 1555 2.03 SSBOND 4 CYS H 25 CYS H 99 1555 1555 2.03 SSBOND 5 CYS H 150 CYS H 206 1555 1555 2.03 SSBOND 6 CYS L 24 CYS L 89 1555 1555 2.03 SSBOND 7 CYS L 135 CYS L 195 1555 1555 2.03 LINK C GLU A1356 N SEP A1357 1555 1555 1.33 LINK C SEP A1357 N ALA A1358 1555 1555 1.33 LINK C ALA A1358 N TPO A1359 1555 1555 1.33 LINK C TPO A1359 N TPO A1360 1555 1555 1.33 LINK C TPO A1360 N ALA A1361 1555 1555 1.33 LINK C ALA A1361 N SEP A1362 1555 1555 1.33 LINK C SEP A1362 N SEP A1363 1555 1555 1.33 LINK C SEP A1363 N SEP A1364 1555 1555 1.33 LINK C SEP A1364 N LEU A1365 1555 1555 1.33 CISPEP 1 PHE B 87 PRO B 88 0 -0.64 CISPEP 2 PHE H 105 TRP H 106 0 -4.17 CISPEP 3 PHE H 156 PRO H 157 0 -0.57 CISPEP 4 SER L 8 PRO L 9 0 -1.64 CISPEP 5 VAL L 95 PRO L 96 0 0.44 CISPEP 6 TYR L 141 PRO L 142 0 0.01 SITE 1 AC1 13 ASP A 121 VAL A 125 ASP A 200 PHE A 201 SITE 2 AC1 13 SER A 211 SER A 215 PHE A 306 PHE A 307 SITE 3 AC1 13 ASN A 310 PHE A 325 VAL A 326 ASN A 329 SITE 4 AC1 13 TYR A 333 SITE 1 AC2 5 ALA A1358 TPO A1359 LYS B 11 PRO B 14 SITE 2 AC2 5 ARG B 165 SITE 1 AC3 6 GLU A1356 TPO A1359 TPO A1360 LYS B 11 SITE 2 AC3 6 ALA B 12 ARG B 165 SITE 1 AC4 8 GLU A1356 SEP A1357 TPO A1360 ALA A1361 SITE 2 AC4 8 LYS B 11 ALA B 12 LYS B 294 HIS B 295 SITE 1 AC5 8 SEP A1357 ALA A1358 ALA A1361 LYS B 11 SITE 2 AC5 8 ARG B 25 LEU B 166 LYS B 294 HIS B 295 SITE 1 AC6 9 ALA A1358 TPO A1359 SEP A1362 PHE B 9 SITE 2 AC6 9 LYS B 10 LYS B 11 ARG B 25 LEU B 166 SITE 3 AC6 9 LYS B 294 SITE 1 AC7 9 TPO A1359 TPO A1360 SEP A1363 ARG B 7 SITE 2 AC7 9 VAL B 8 PHE B 9 LYS B 10 SER L 31 SITE 3 AC7 9 ARG L 67 SITE 1 AC8 9 ALA A1361 SEP A1364 LEU A1365 ARG B 7 SITE 2 AC8 9 VAL B 8 LYS B 10 LYS B 107 SER L 31 SITE 3 AC8 9 ARG L 67 SITE 1 AC9 6 SEP A1362 LEU A1365 ARG B 7 VAL B 8 SITE 2 AC9 6 LYS B 10 LYS B 107 SITE 1 AD1 7 SEP A1363 ALA A1366 LYS A1367 THR B 6 SITE 2 AD1 7 ARG B 7 ARG B 103 LYS B 107 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000